Sino Biological Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 18.09% vs 1.97% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 42.04% vs -48.40% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "183.40",
          "val2": "155.30",
          "chgp": "18.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.00",
          "val2": "33.60",
          "chgp": "-10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.90",
          "chgp": "-22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.70",
          "val2": "-0.80",
          "chgp": "937.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.10",
          "val2": "22.60",
          "chgp": "42.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "163.80%",
          "val2": "52.60%",
          "chgp": "11.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.07% vs -5.04% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.16% vs -53.13% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "693.90",
          "val2": "613.70",
          "chgp": "13.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "191.30",
          "val2": "129.80",
          "chgp": "47.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "4.60",
          "chgp": "-26.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "24.60",
          "val2": "4.90",
          "chgp": "402.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "147.70",
          "val2": "121.90",
          "chgp": "21.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "129.80%",
          "val2": "47.40%",
          "chgp": "8.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

183.40

155.30

18.09%

Operating Profit (PBDIT) excl Other Income

30.00

33.60

-10.71%

Interest

0.70

0.90

-22.22%

Exceptional Items

6.70

-0.80

937.50%

Consolidate Net Profit

32.10

22.60

42.04%

Operating Profit Margin (Excl OI)

163.80%

52.60%

11.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 18.09% vs 1.97% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 42.04% vs -48.40% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

693.90

613.70

13.07%

Operating Profit (PBDIT) excl Other Income

191.30

129.80

47.38%

Interest

3.40

4.60

-26.09%

Exceptional Items

24.60

4.90

402.04%

Consolidate Net Profit

147.70

121.90

21.16%

Operating Profit Margin (Excl OI)

129.80%

47.40%

8.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.07% vs -5.04% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.16% vs -53.13% in Dec 2024

All Annual Results